The URI Institutional Review Board (IRB) reviews research projects which involve human subjects to ensure that two broad standards are upheld: (1) that subjects are not placed at undue risk, and (2) that they give un-coerced, informed consent to their participation.
With representation from a wide range of scientific disciplines and from outside the academic community, the IRB gives individualized attention to the numerous research projects at the University. URI’s Human Research Protection Program operates under Federalwide Assurance # FWA00003132. The IRB is governed by the IRB Governance and Operating Policies 1.2020.
Students as Research Subjects
Students at the University of Rhode Island who are over the age of adulthood (18 years of age) in the state of Rhode Island may volunteer to participate in research activities. Children under the age of 18 must have parental permission as well. Faculty who require student participation in research for course credit (or extra credit) must adhere to the following guidelines:
- The research activity must have prior IRB approval.
- Research may not involve more than minimal risk.
- Participation must be voluntary. Therefore, participation in a specific project may not be a course requirement. It could be offered as extra credit if other options for the extra credit were provided.
- All elements of the informed consent process must be followed.
- If participation is to take place in the classroom, an alternative activity must be provided for those individuals who do not choose to participate.
- In no way may a student’s grade be affected by his/her desire not to participate.
- Students may withdraw from a study at any time without reprisal.
Research involving normal educational practices such as the effectiveness of or the comparison among instructional techniques is allowed without IRB review if conducted in commonly accepted educational settings and if the research is instructional in nature. (45CFR46.101b1)
Federal Guidance
- DHHS Office of Human Research Protections (OHRP) provides leadership in the protection of the rights, welfare, and well-being of subjects involved in research conducted or supported by the U.S. Department of Health and Human Services (HHS).
- Code of Federal Regulations for research involving human subjects (45 CFR 46). Basic regulations governing the protection of human subjects in research supported or conducted by HHS. The regulations require basic protections to human subjects involved in both biomedical and behavioral research conducted or supported by HHS. The statutory authority for the HHS regulations derives from 5 U.S.C. 301; 42 U.S.C. 300v-1(b); and 42 U.S.C. 289.
- US FDA Information on research involving human subjects. (21 CFR 50,56). The US Food and Drug Administration (US FDA) is an HHS agency that regulates clinical investigations of products under its jurisdiction, such as drugs, biological products, and medical devices. FDA regulations are published in title 21 of the CFR (21 CFR part 50, Protection of Human Subjects; 21 CFR part 56, Institutional Review Boards; 21 CFR part 312, Investigational New Drug Application; 21 CFR part 812, Investigational Device Exemptions).
- HIPAA Privacy Rule is the Federal protection for the privacy of personal health information. The Privacy Rule establishes a category of health information, defined as protected health information (PHI), which a covered entity may only use or disclose to others in certain circumstances and under certain conditions. In general, the Privacy Rule requires an individual to provide signed permission before a covered entity can use or disclose the individual’s PHI for research purposes. Under certain circumstances, however, the Privacy Rule permits a covered entity to use or disclose PHI for research without an individual’s Authorization. One way a covered entity can use or disclose PHI for research without an Authorization is by obtaining proper documentation of a waiver of the Authorization requirement by an Institutional Review Board (IRB).
- Certificate of Confidentiality is issued by the National Institutes of Health (NIH) to protect identifiable research information from forced disclosure. They allow the investigator and others who have access to research records to refuse to disclose identifying information on research participants in any civil, criminal, administrative, legislative, or other proceeding, whether at the federal, state, or local level.
- NIH Policy and Guidelines on the Inclusion of Children in Research is designed to increase the participation of children in research so that adequate data will be developed to support the treatment modalities for disorders and conditions that affect adults and may also affect children.
- NIH Guideline on the Inclusion of Women and Minorities in Research is designed to ensure participation of women and members of minority groups and their subpopulations in all NIH-supported biomedical and behavioral research projects involving human subjects.
